This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Singapore O&G Past Earnings Performance
Past criteria checks 1/6
Key information
-9.3%
Earnings growth rate
-9.2%
EPS growth rate
| Healthcare Industry Growth | 9.7% |
| Revenue growth rate | 9.0% |
| Return on equity | 19.6% |
| Net Margin | 19.6% |
| Next Earnings Update | 11 Aug 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Singapore O&G makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 43 | 8 | 1 | 0 |
| 30 Sep 21 | 43 | 9 | 1 | 0 |
| 30 Jun 21 | 43 | 10 | 1 | 0 |
| 31 Mar 21 | 42 | 10 | 1 | 0 |
| 31 Dec 20 | 40 | 9 | 1 | 0 |
| 30 Sep 20 | 40 | -2 | 1 | 0 |
| 30 Jun 20 | 39 | -2 | 1 | 0 |
| 31 Mar 20 | 40 | -1 | 1 | 0 |
| 31 Dec 19 | 40 | -1 | 1 | 0 |
| 30 Sep 19 | 38 | 8 | 2 | 0 |
| 30 Jun 19 | 37 | 8 | 2 | 0 |
| 31 Mar 19 | 35 | 9 | 2 | 0 |
| 31 Dec 18 | 35 | 9 | 2 | 0 |
| 30 Sep 18 | 34 | 11 | 2 | 0 |
| 30 Jun 18 | 32 | 11 | 2 | 0 |
| 31 Mar 18 | 31 | 9 | 2 | 0 |
| 31 Dec 17 | 30 | 9 | 2 | 0 |
| 30 Sep 17 | 29 | 8 | 1 | 0 |
| 30 Jun 17 | 29 | 9 | 1 | 0 |
| 31 Mar 17 | 29 | 9 | 1 | 0 |
| 31 Dec 16 | 29 | 9 | 1 | 0 |
| 30 Sep 16 | 26 | 8 | 1 | 0 |
| 30 Jun 16 | 23 | 7 | 1 | 0 |
| 31 Mar 16 | 19 | 6 | 1 | 0 |
| 31 Dec 15 | 17 | 5 | 1 | 0 |
| 30 Sep 15 | 16 | 5 | 1 | 0 |
| 30 Jun 15 | 15 | 4 | 1 | 0 |
Quality Earnings: 1D8 has high quality earnings.
Growing Profit Margin: 1D8's current net profit margins (19.6%) are lower than last year (23.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1D8's earnings have declined by 9.3% per year over the past 5 years.
Accelerating Growth: 1D8's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1D8 had negative earnings growth (-11.9%) over the past year, making it difficult to compare to the Healthcare industry average (12%).
Return on Equity
High ROE: 1D8's Return on Equity (19.6%) is considered low.